A Review of Animal Laboratory Practice in the COVID-19 and Safety Concerns

Document Type : Review


1 Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3 UroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, Campinas, São Paulo, Brazil


The research in biomedical sciences is based on primary research on animals. Due to the coronavirus disease-2019 (COVID-19) pandemic, many research projects involving animal studies have faced interruptions due to the raised concerns about the safety of working with animals The disruption in such research projects has raised significant concerns in biomedical scientific research worldwide. Assessing and evaluating the safety and feasibility of research projects on animal models seems necessary. This study provides evidence of the feasibility of continuing research activities in animal laboratories during the COVID-19 pandemic. According to the results of studies, the risk of COVID-19 is low in routine laboratory animals, including mice, rats, and pigs.
By examining the available data from our animal laboratory and continuing research activities on low-risk animals, with adequate safety and personal protective equipment available at the facility, animal studies could be carried forward without endangering the safety of the researcher and society.


  • Many research projects involving animal studies have faced interruptions due to the coronavirus disease-2019 (COVID-19) pandemic.
  • The disruption in such research projects have raised significant concerns in biomedical scientific research worldwide.
  • This study provides evidence on the feasibility of continuing the research activities in animal laboratories during the COVID-19 pandemic.



Different animals have been used in medical research since the ancient Greek civilization (1). The discovery of biological and genetic similarities between humans and animals has led to the development of animal models in medicine and biological research (1), rendering the role of animal laboratories in the development of biological sciences indispensable. 

With the global pandemic of coronavirus disease-2019 (COVID-19) around the world, veterinary societies have become concerned about the possibility of contamination of laboratory animals with COVID-19 and the possibility of cross-species transmission to humans. Therefore, most laboratories and animal studies have been closed or restricted their activities by reducing staff presence to reduce any possible contamination (2). All biomedical sciences depend heavily on animal experiments therefore, such a global halt in all animal study and research projects during the COVID-19 pandemic could lead to a disruption in the evolution of knowledge and science with grave consequences on clinical and daily life use. Experts still ask many global questions about whether it is ethical and feasible to continue the current projects or start new ones. Also, given the cost and time spent on each project, the cost-effectiveness of such research might remain questionable to the extent that some authorities assess the complete shutdown of animal laboratories and projects as an option.


Evidence acquisition

Almost 75% of human infectious diseases are transmitted from animals (3). Genetic sequencing analysis has shown that COVID-19 is closely related to other viruses in the coronavirus family that circulate in bats (4). Also, in some reports, bats have been identified as the natural source of the emergence of COVID-19 (5). These reports raised concerns about the transmission of the virus from animals to humans. But so far, there is not enough scientific evidence for the virus's origin and how it is transmitted to humans (6). On the other hand, the first person with COVID-19 in Wuhan, China, had no connection with the bat or the seafood market (7). It should also be noted that there is very little evidence of animals being infected with COVID-19 (some domestic cats, dogs, minks, and a tiger), and infection in these animals is likely to be transmitted from infected owners or other people (8). Also, there is no evidence that the disease is spread by animals worldwide (6). The severity of COVID-19 in animals is also low, and COVID-19 generally presents without symptoms or some mild clinical symptoms. One of the infected animals was an asymptomatic dog belonging to a COVID-19 patient in Hong Kong (9). COVID-19 infection in this dog was confirmed by reverse transcription-polymerase chain reaction (RT-PCR), and serological tests revealed the presence of COVID-19-specific antibodies (10). However, due to the low viral titers observed, the virus did not grow and remained weak in this dog, and the chance of infectious transmission was very low or nonexistent (10). Therefore, COVID-19 could sometimes infect an animal, which might not lead to clinical illness nor become transmissible to other animals and people. Another infected dog in Hong Kong was a German shepherd belonging to a person infected with COVID-19 (11). The dog had no clinical symptoms, while the polymerase chain reaction (PCR) test was positive. Viral sequencing of this dog and its owner showed that both viruses were identical, and the dog was infected by its owner. Like the previous animal, in this case, the viral load was very low, and there was no possibility of transmission from this dog (12). Other infected animals were a cat in Hong Kong and a cat in Bruxelles (13). Despite the positive PCR test in these two cats, no evidence of disease transmission to other human or animals were found. Also, on April 5, a positive molecular test for COVID-19 was reported on a tiger at the Wildlife Conservation Society’s Bronx Zoo with a clinical sign of a dry cough. Zoo officials believe the tiger may have been infected by its guard (14). However, it should be noted that positive reverse transcription–PCR (RT-PCR) results do not confirm the presence of the living, replicating virus, and it does not necessarily mean the subject is contagious (8). Finally, there is no definitive evidence that animals play a role in the distribution of COVID-19 (4).


Risk of COVID-19 infection in different animals 

Because of the genetic differences between laboratory animals, the risk of developing COVID-19 in each species is different (20). Preliminary studies investigating the susceptibility of commonly used animals to  COVID-19 have shown that cats are the most susceptible to being infected by COVID-19 in the laboratory, and the virus can cause clinical disease (6). In the second place, ferrets are susceptible to the virus but less likely to develop the disease than cats (6). Dogs are also likely susceptible to the virus but are much less likely to present clinical disease (6). In the laboratory, fruit bats were also infected with COVID-19, but their infection did not lead to clinical disease, and most probably, they are not contagious (6). Monkeys are also susceptible to COVID-19, and infection occurs in them with mild symptoms (15). Meanwhile, these studies have shown that poultry and pigs resist COVID-19 infection (6). In biomedical studies, mice and rats are the most widely used animals (16), and their susceptibility is worth examining. The COVID-19 virus uses angiotensin-converting enzyme 2 (ACE2) protein to enter its host cell (17). Examination of the ACE2 receptor for the entry of the COVID-19 virus into the cells showed that the mouse and rat ACE2 were unable to transmit the virus into the cells (18, 19). Hence, in COVID-19 vaccine studies, transgenic mice and rats that express human ACE2 are being used (19). According to the abovementioned reports, there are far fewer safety concerns about working with mice, rats, poultry, and pigs (all with wild-type ACE2 receptor genes) in animal laboratories during the COVID-19 pandemic. 

The susceptibility of different mammalian species (rhesus, macaque, marmoset, hamster, rabbit, ferret, rat, mouse, pig, and bat) to COVID-19 has also been evaluated in silico. Hence, 29 essential ACE2 amino acids responsible for the entry of COVID-19 into the host cell in some species were compared with the human ACE2. The results of the alignment analysis of this protein showed that rhesus macaque ACE2 was 100% similar to humans, followed by marmosets (90%), hamsters (86%), rabbits (83%), pigs (76%), bats (69%), mouse (62%), ferrets (59%) and rats (55%) (18). Therefore, in silico assessment, the rhesus macaque, marmosets, and hamsters are the most sensitive species. 


Our experience in the time of the COVID-19 pandemic

At the time of the outbreak of COVID-19 in our animal laboratory of the Urology Research Center of Tehran University of Medical Sciences, eight animal projects (84 rats) were in progress. During the first wave of the pandemic, these projects were carried on by regulating and reducing the presence of laboratory staff and ensuring the health of those entering the laboratory. Any employee who developed symptoms of (fever, cough, muscle pain, and throat pain) was removed from the working list and was denied access to the facility for 14 days. Also, physical spacing was increased between the animals. No clinical infections and COVID-19 viruses were detected among our staff nor studied rats, and all eight projects were completed according to the respective protocols (Figure 1). Of course, we noted that in quarantine conditions, the provision of materials and equipment is slower and more complex than at other times. Therefore, with proper storage and the necessary coordination regarding out-of-laboratory equipment (such as computerized tomography (CT) scan device and pathology equipment), we did not encounter any problems carrying out protocols without serious deviations. In projects that required the removal of rat organs for autopsy, the organ was collected, and pathological examinations were performed in full compliance with the required biosafety principles. At the end of the project, all the animals were euthanized and discarded according to local biosafety protocols.


Figure 1. The Animal Laboratory of the Urology Research Center of Tehran University of Medical Sciences activity during the COVID-19 pandemic. A) Creating social distance between animals. B) Check the health of animals during projects. C) Provide the necessary equipment (for example, a CT scan) to continue any project. D) Keeping animals with children on separate shelves.
CT: Computerized Tomography
During the pandemic of COVID-19, animal laboratories must adapt to special conditions far beyond simple biosafety precautions to complete their ongoing projects. It could be beneficial to be aware of the sensitivity of the selected animal to the COVID-19 infection. Also, re-evaluating the supply chain for materials and equipment during quarantine is of utmost importance for successfully executing research protocols. Daily health checks of laboratory staff and monitoring of animals’ clinical symptoms are essential. Finally, laboratory staff needs to have complete personal protective equipment.
Authors’ contributions
All authors had an equal contribution. 
Special thanks to the Urology Research Center (URC), Tehran University of Medical Sciences (TUMS). 
Conflict of interest 
All authors declare that there is not any kind of conflict of interest.
There is no funding.
Ethical statement 
Not applicable.
Data availability 
Not applicable.
ACE2         Angiotensin-converting enzyme 2 
CT             Computerized tomography 
PCR           Polymerase chain reaction 
RT-PCR     Reverse transcription–PCR
1. Baumans V. Baumans, V. Science-based assessment of animal welfare: laboratory animals. Rev. Sci. Tech. 24, 503-513. Revue scientifique et technique (International Office of Epizootics). 2005;24:503-13.
2. Brown P. A Word from OLAW: COVID-19 guidance. Lab Animal. 2020;49(5):132-.
3. Kruse H, kirkemo A-M, Handeland K. Wildlife as source of zoonotic infections. Emerg Infect Dis. 2004;10(12):2067-72.
4. Centers for Disease Control and Prevention. COVID-19 and Animals 2020 [Available from: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/animals.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprepare%2Fanimals.html.
5. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.
6. World Organisation for Animal Health. Questions and Answers on the 2019 Coronavirus Disease (COVID-19) 2020. Available from: https://www.oie.int/en/scientific-expertise/specific-information-and-recommendations/questions-and-answers-on-2019novel-coronavirus/.
7. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-2014; The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020;91:264-6.
8. Parry NMA. COVID-19 and pets: When pandemic meets panic. Forensic Science International: Reports. 2020;2:100090-.
9. Agriculture Fisheries and Conservation Department (AFCD). Detection of low level of COVID-19 virus in pet dog. 2020 [Available from: https://www.afcd.gov.hk/english/publications/publications_press/pr2342.html.
10. Almendros A. Can companion animals become infected with Covid-19? Vet Rec. 2020;186(12):388-9.
11. PRO/AH/EDR>COVID-19 update (45). China (Hong Kong) animal, dog, 2nd case PCR Positive. 2020.
12. Leroy EM, Ar Gouilh M, Brugère-Picoux J. The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic. One Health. 2020:100133.
13. SciCoM - Comite Scientifique de l’Institué auprès de l’Agence Fédérale pour la Sécurité de la Chaîne Alimentaire. Risque zoonotique du SARS-CoV2 (Covid-19) associé aux animaux de compagnie: infection de l’animal vers l’homme et de l’homme vers l’animal. 2020.
14. United States Department of Agriculture AaPHIS. USDA Statement on the Confirmation of COVID-19 in a Tiger in New York 2020 [Available from: https://www.aphis.usda.gov/aphis/newsroom/news/sa_by_date/sa-2020/ny-zoo-covid-19.
15. Quartz daily brief. How monkeys, ferrets, and horses are helping scientists fight Covid-19 2020 [Available from: https://qz.com/1837094/how-lab-animals-are-helping-scientists-fight-covid-19/.
16. Max Planck Institute for Developmental Biology. Number of laboratory animals in Germany 2009 [Available from: http://www.eb.tuebingen.mpg.de/research/animal-research/laboratory-animals-and-animal-welfare/numbers-laboratory-animals-in-germany.html.
17. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-80.e8.
18. Chan JF-W, Zhang AJ, Yuan S, Poon VK-M, Chan CC-S, Lee AC-Y, et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clinical Infectious Diseases. 2020.
19. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62.